Answers are grounded in this paper and cite their sources.
Synthetic cannabinoids (SCs) are a structurally diverse class of new psychoactive substances with scarce toxicological data and rapidly evolving structures that challenge risk assessment. This study applied the CASE Ultra, version 1.9.0.8 expert system to predict the genotoxic potential of 18 SCs identified in Brazilian seizures and the literature, and to evaluate how subtle structural modifications may influence mutagenicity-related alerts. Predictions were generated combining the GT_EXPERT (rule-based), GT1_BMUT (statistical bacterial reverse mutagenicity model), and the integrated Konsolidator module. For each compound, the software provided positive, negative, or inconclusive outputs, identifying structural alerts and deactivating fragments, as well as listed database analogs. Inconclusive or conflicting results underwent expert review considering structural similarity, DNA accessibility, metabolic plausibility, and supporting evidence. Compounds showing positive or inconclusive outcomes were further evaluated using three complementary QSAR platforms (VEGA Hub version 1.1.5, Toxtree 3.1.0, and OECD QSAR Toolbox version 4.8) to assess the consistency of structural alerts across different computational approaches. Whenever available, predictions were interpreted in light of published experimental data. Most SCs were classified as negative by the integrated CASE Ultra prediction, suggesting an overall low predicted bacterial reverse mutagenicity risk within the evaluated group. JWH-018 was the only compound consistently classified as positive, whereas CH-FUBIATA yielded an inconclusive prediction due to the coexistence of activating and deactivating structural features. Comparative analysis demonstrated good agreement between CASE Ultra and VEGA Hub, with both platforms identifying similar mutagenicity-associated structural alerts for JWH-018 and CH-FUBIATA. In contrast, neither Toxtree nor the OECD QSAR Toolbox identified structural alerts for these compounds, likely reflecting the limited representation of contemporary SCs within their underlying knowledge bases. A simulated structural modification of PX-2 demonstrated that removal of a deactivating amine group converted a negative prediction into a positive one, illustrating how minor chemical changes may substantially alter predicted genotoxic risk. Conversely, the predicted metabolites of PX-1 and PX-2 retained negative classifications, indicating that molecular modifications do not inherently alter mutagenic potential and that distinct structural changes, whether resulting from deliberate chemical modification or metabolic biotransformation, may lead to different genotoxicity outcomes. These findings demonstrate that predicted bacterial reverse mutagenicity is determined by the interaction between activating and deactivating structural features within the overall molecular architecture rather than by isolated pharmacophoric elements. The concordance observed between CASE Ultra and VEGA Hub supports the mechanistic interpretation of the identified structural alerts, whereas the absence of alerts in other expert systems underscores the need to expand QSAR training data sets for emerging substances. Overall, integrated in silico approaches represent valuable tools for the early prioritization of toxicological risks, although further experimental validation remains essential to strengthen predictive confidence.
No takes yet. Share an insight, caveat, or question.
Messias et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: